Titan Medical Inc (TMDIF)

[pontiacg6]

Titan Medical Inc. Announces Public Financing November 3rd, 2015

TORONTO, ON–(Marketwired – November 03, 2015) –

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (OTCQX: TITXF) has announced that it intends to commence an offering of units (the “Units“), each Unit to consist of one common share and a partial or whole common share purchase warrant of the Company, by way of a prospectus supplement (the “Prospectus Supplement“) to the Company’s base shelf prospectus dated August 18, 2015 (together with the Prospectus Supplement, the “Prospectus“), to be filed with securities regulators in Ontario, British Columbia and Alberta and on a private placement basis in the United States, on a fully marketed “best efforts” basis, with the pricing and terms of the offering to be determined in the context of the market (together, the “Offering“).

The Company has engaged a U.S. placement agent as its sole agent for the Offering in the United States and Octagon Capital Corporation to serve as lead agent and sole book-runner in connection with the Offering in Canada.

The Offering is subject to a number of conditions, including, without limitation, receipt of all regulatory approvals. The Units will be qualified for distribution in Ontario, British Columbia and Alberta pursuant to the Prospectus. The net proceeds of the Offering will be used for ongoing development and commercialization of robotic surgical technologies and general working capital requirements.